Atopic dermatitis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! colspan=" | ! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| rowspan="5" |Associated factors | |||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
Line 50: | Line 50: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Incidence is highest during infancy and early childhood. | * Incidence is highest during infancy and early childhood. | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 89: | Line 85: | ||
* Psoriasiform hyperplasia | * Psoriasiform hyperplasia | ||
* Dyskeratosis | * Dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | |||
* Family history of atopic dermatitis or other [[atopy]] | |||
* Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]]) | |||
* Active and passive exposure to tobacco | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Hayfever | * Hayfever | ||
Line 100: | Line 100: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Any | | align="center" style="background:#F5F5F5;" |Any | ||
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | | align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | ||
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated papules | | align="center" style="background:#F5F5F5;" | Erythematous well-demarcated papules | ||
Line 118: | Line 115: | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" | | |||
* Contact with allergens in the past 1-2 days | |||
* Positive family history | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Prevention by avoidance | * Prevention by avoidance | ||
Line 127: | Line 127: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Any, more occupational exposure | | align="center" style="background:#F5F5F5;" |Any, more occupational exposure | ||
| align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure | | align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure | ||
| align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface | | align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface | ||
Line 146: | Line 144: | ||
* Intraepidermal vesicles or bullae | * Intraepidermal vesicles or bullae | ||
* Necrosis of keratinocytes | * Necrosis of keratinocytes | ||
| align="center" style="background:#F5F5F5;" | | |||
* Cumulative exposure to irritants | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Negative hypersensitivity tests | * Negative hypersensitivity tests | ||
Line 155: | Line 155: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, onset during the infancy and peak during 3rd-4th decades | | align="center" style="background:#F5F5F5;" | Any, onset during the infancy and peak during 3rd-4th decades | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 180: | Line 176: | ||
* Psoriasiform hyperplasia | * Psoriasiform hyperplasia | ||
* Neutrophils at the margins | * Neutrophils at the margins | ||
| align="center" style="background:#F5F5F5;" | | |||
* Stress | |||
* Cold, dry weather can cause flare ups | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Super infection with bacteria and candida | * Super infection with bacteria and candida | ||
Line 191: | Line 191: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, 2 peaks of onset 30-39 years and 50-59 years | | align="center" style="background:#F5F5F5;" | Any, 2 peaks of onset 30-39 years and 50-59 years | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | | align="center" style="background:#F5F5F5;" | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | ||
Line 215: | Line 207: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
* Smoking | |||
* Skin trauma | |||
* Alcohol abuse | |||
* Stress | |||
* Cold weather | |||
* Vitamin D deficiency | |||
* Drugs | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
Line 223: | Line 223: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, peak at 30-50 years of age | | align="center" style="background:#F5F5F5;" | Any, peak at 30-50 years of age | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | Lichenified and erythematous, pruritic exudative plaque, and excoriations | | align="center" style="background:#F5F5F5;" | Lichenified and erythematous, pruritic exudative plaque, and excoriations | ||
Line 246: | Line 240: | ||
* Thick granular zone | * Thick granular zone | ||
* Acanthosis | * Acanthosis | ||
| align="center" style="background:#F5F5F5;" | | |||
* Emotional stress | |||
* Sleep disturbances | |||
* Dry weather | |||
* Sweating | |||
* Excessive dryness | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Sexual dysfunction | * Sexual dysfunction | ||
Line 259: | Line 259: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Usually in infancy | | align="center" style="background:#F5F5F5;" | Usually in infancy | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 284: | Line 281: | ||
* Thick stratum corneum | * Thick stratum corneum | ||
* Basket-weave pattern of stratum corneum | * Basket-weave pattern of stratum corneum | ||
| align="center" style="background:#F5F5F5;" | | |||
* Dry and cold weather | |||
* Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Increased risk for atopy, including asthma, allergies, and atopic dermatitis | * Increased risk for atopy, including asthma, allergies, and atopic dermatitis | ||
Line 292: | Line 292: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | | align="center" style="background:#F5F5F5;" | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
Line 316: | Line 309: | ||
* Spongiosis | * Spongiosis | ||
* Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils | * Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils | ||
| align="center" style="background:#F5F5F5;" | | |||
* Temperature changes (particularly winter) | |||
* Emotional stress | |||
* Dry skin | |||
* Environmental irritants | |||
* Recent surgery | |||
* Medications like topical antibiotic creams and isotretinoin | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Superinfection with ''staphylococcus aureus'' | * Superinfection with ''staphylococcus aureus'' | ||
Line 325: | Line 325: | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | Affects neonates | | align="center" style="background:#F5F5F5;" | Affects neonates | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 360: | Line 358: | ||
* Dyskeratosis, | * Dyskeratosis, | ||
* Dermal inflammatory infiltrate including neutrophils and eosinophils | * Dermal inflammatory infiltrate including neutrophils and eosinophils | ||
| align="center" style="background:#F5F5F5;" | | |||
* Atopic diseases including food allergy and strong family history of asthma, atopic dermatitis and allergic rhinitis | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
** Systemic and skin superinfections | ** Systemic and skin superinfections | ||
Line 371: | Line 371: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ||
Multiple | Multiple | ||
Line 384: | Line 383: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
Line 411: | Line 411: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, peak among children >5 years of age and young adults | | align="center" style="background:#F5F5F5;" | Any, peak among children >5 years of age and young adults | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 432: | Line 427: | ||
* Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies) | * Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies) | ||
* H&E stain - inwards indentation of the epidermis | * H&E stain - inwards indentation of the epidermis | ||
| align="center" style="background:#F5F5F5;" | | |||
* Often asymptomatic | |||
* Tender or pruritic skin lesions | |||
* Self resolve within 2 months | |||
* Immunocompetent patients present with extensive and severe infections | |||
| align="center" style="background:#F5F5F5;" | mMlluscum contagiosum | | align="center" style="background:#F5F5F5;" | mMlluscum contagiosum | ||
Line 441: | Line 441: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Multiple | | align="center" style="background:#F5F5F5;" |Multiple | ||
| align="center" style="background:#F5F5F5;" | Erythematous papular lesions | | align="center" style="background:#F5F5F5;" | Erythematous papular lesions | ||
Line 454: | Line 452: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
* Positive family history | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
Line 462: | Line 462: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, mean age of disease onset is 2nd-4th decade | | align="center" style="background:#F5F5F5;" | Any, mean age of disease onset is 2nd-4th decade | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 484: | Line 481: | ||
* Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin | * Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin | ||
* Sub-epidermal vacuolization | * Sub-epidermal vacuolization | ||
| align="center" style="background:#F5F5F5;" | | |||
* Intermittent pruritic papules and vesicles | |||
* Associated small intestine celiac disease with villous atrophy and crypt hyperplasia | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Abdominal bloating, pain, diarrhea, or constipation | * Abdominal bloating, pain, diarrhea, or constipation | ||
Line 495: | Line 495: | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | Seen almost exclusively in males in infancy | | align="center" style="background:#F5F5F5;" | Seen almost exclusively in males in infancy | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 527: | Line 520: | ||
* Epidermal psoriasiform [[hyperplasia]] | * Epidermal psoriasiform [[hyperplasia]] | ||
* Marked intercellular [[edema]] with spongiotic vesiculation | * Marked intercellular [[edema]] with spongiotic vesiculation | ||
| align="center" style="background:#F5F5F5;" | | |||
* Blleeding: severe thrombocytopenia, | |||
* Eczema - similar to atopic dermatitis | |||
* Recurrent sino-pulmonary infections | |||
* Opportunistic infections. | |||
* Autoimmune diseases | |||
* Malignancies | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* ↑ serum immunoglobulin A (IgA) levels | * ↑ serum immunoglobulin A (IgA) levels | ||
Line 538: | Line 538: | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | Rare, begin in infancy | | align="center" style="background:#F5F5F5;" | Rare, begin in infancy | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 573: | Line 564: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Eosinophil-rich infiltration around the hair follicles | * Eosinophil-rich infiltration around the hair follicles | ||
| align="center" style="background:#F5F5F5;" | | |||
* Cold abscesses | |||
* Pruritic eczema | |||
* Allergic diseases | |||
* Noneruption of permanent teeth | |||
* Multiple bone fractures and scoliosisis | |||
* Peripheral T-cell lymphoma | |||
* Coronary artery aneurysms | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | * | ||
Line 582: | Line 582: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Mean age is 55- 60 years | | align="center" style="background:#F5F5F5;" | Mean age is 55- 60 years | ||
| align="center" style="background:#F5F5F5;" | Multiple | | align="center" style="background:#F5F5F5;" | Multiple | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 613: | Line 608: | ||
* Epidermis is spared or has minimal spongiosis | * Epidermis is spared or has minimal spongiosis | ||
* Band-like dermal infiltrate of lymphocytes and and histiocytes | * Band-like dermal infiltrate of lymphocytes and and histiocytes | ||
| align="center" style="background:#F5F5F5;" | | |||
* Increased risk of : | |||
** Severe viral and bacterial infections | |||
** Secondary malignancies, especially lymphomas | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Staging of Mycosis fungoides is based upon: | * Staging of Mycosis fungoides is based upon: | ||
Line 628: | Line 627: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ||
Multiple | Multiple | ||
Line 641: | Line 639: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|} | |} |
Revision as of 15:06, 25 October 2018
Atopic dermatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Atopic dermatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis |
Risk calculators and risk factors forAtopic dermatitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Differentiating Atopic Dermatitis from other Diseases
Category | Diseases | Etiology | Inherited | Acquired | Clinical manifestations | Para-clinical findings | Associated factors | Additional findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | Symptoms | Physical examination | ||||||||||||||||
Lab Findings | Histopathology | |||||||||||||||||
Appearance | Itching | Fever | Tenderness | Other | CBC | Serum IgE | ||||||||||||
Single/
Multiple |
Rash | Involved areas | Pustule | WBC | ||||||||||||||
Skin disorders | Atopic dermatitis |
|
+ | + |
|
Multiple |
|
– | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
|
| |
Allergic contact dermatitis[1] |
|
– | + | Any | May be multiple after 1-2 days of exposure | Erythematous well-demarcated papules | Surrounding the area in contact with the offending agent | – | + | – | + |
|
Nl to ↑
(Eosinophilia) |
Nl | NA |
|
| |
Irritant contact dermatitis[2] |
|
– | + | Any, more occupational exposure | Usually single immediately after the exposure | Well-demarcated red patch with a glazed surface | Any area in contact with the irritant | – | + | – | + |
|
Nl | Nl |
|
|
| |
Seborrheic dermatitis |
|
– | + | Any, onset during the infancy and peak during 3rd-4th decades | Multiple |
|
Scalp, face, trunk, postauricular, diaper area and axilla | + | + | – | – |
|
Nl | Nl |
|
|
| |
Psoriasis |
|
+ | + | Any, 2 peaks of onset 30-39 years and 50-59 years | Multiple | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales |
|
+ | + | _ | + |
|
|
|||||
Lichen simplex [3]chronicus |
|
– | + | Any, peak at 30-50 years of age | Multiple | Lichenified and erythematous, pruritic exudative plaque, and excoriations | Scalp, head, neck, hands, arms, and genitals areas | – | + | – | – |
|
Nl | Nl |
|
|
| |
Ichthyosis vulgaris[4] |
|
+ | + | Usually in infancy | Multiple |
|
|
– | – | – | – |
|
Nl | Nl |
|
|
| |
Nummular dermatitis (discoid eczema) | Unknown | – | + | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | Multiple | Nl |
|
– | + | – | – |
|
Nl | Nl |
|
|
| |
Netherton's syndrome[5] | Autosomal recessive mutations in the serine protease inhibitor of Kazal type 5 gene (SPINK5), encoding LEKTI, a serine protease inhibitor | + | – | Affects neonates | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
|
| |
Diseases | Etiology | Inherited | Acquired | Demography | Single/
Multiple |
Rash | Involved areas | Pustule | Itching | Fever | Tenderness | Other | WBC | ESR/CRP | Histopathology | Associated factors | Additional findings | |
Infection | Dermatophytes | |||||||||||||||||
Molluscum contagiosum | Molluscum contagiosum virus inoculation through direct skin contact | – | + | Any, peak among children >5 years of age and young adults | Multiple |
|
|
– | + | – | – | If molluscum contagiosum is acquired as sexually transmitted disease, it involves, groin and genital region. | Nl | Nl |
|
|
mMlluscum contagiosum
lesions on the eyelid may lead to follicular or papillary conjunctivitis . | |
Scabies | Multiple | Erythematous papular lesions | Flexor wrists, finger webs and genitalia | +++ |
|
|||||||||||||
Immunologic disorders | Dermatitis herpetiformis[6] | Autoimmune disorder as a result of gluten sensitivity leading to the formation of IgA antibodies | – | + | Any, mean age of disease onset is 2nd-4th decade | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
|
|
Immune deficiency | Wiskott-Aldrich syndrome[7] |
|
+ | – | Seen almost exclusively in males in infancy | Multiple |
|
Rash can involve lesions located at the same areas of classical atopic dermatitis:
extensor surfaces of extremities and cheeks or scalp |
– | + | – | – | Infants can present with petechiae, prolonged bleeding from umbilicus or circumcision, purpura, hematemesis, melena, epistaxis, hematuria or unusal bruising | Nl to ↑
(Eosinophilia) |
↑ |
|
|
|
Hyper-IgE syndrome[8] |
|
+ | – | Rare, begin in infancy | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
|
| |
Malignancy | Mycosis fungoides | Clonal expansion of CD4+ memory T cells (CD45RO+) | – | + | Mean age is 55- 60 years | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
|
|
Category | Diseases | Etiology | Inherited | Acquired | Demography | Single/
Multiple |
Rash | Involved areas | Pustule | Itching | Fever | Tenderness | Other | WBC | ESR/CRP | Histopathology | Associated factors | Additional findings |
References
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
- ↑ Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.
- ↑ Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G (July 2017). "Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade". Open Access Maced J Med Sci. 5 (4): 556–557. doi:10.3889/oamjms.2017.133. PMC 5535688. PMID 28785363.
- ↑ Thyssen JP, Godoy-Gijon E, Elias PM (June 2013). "Ichthyosis vulgaris: the filaggrin mutation disease". Br. J. Dermatol. 168 (6): 1155–66. doi:10.1111/bjd.12219. PMID 23301728.
- ↑ Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (June 2000). "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome". Nat. Genet. 25 (2): 141–2. doi:10.1038/75977. PMID 10835624.
- ↑ Kárpáti S (2012). "Dermatitis herpetiformis". Clin. Dermatol. 30 (1): 56–9. doi:10.1016/j.clindermatol.2011.03.010. PMID 22137227.
- ↑ Buchbinder D, Nugent DJ, Fillipovich AH (2014). "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments". Appl Clin Genet. 7: 55–66. doi:10.2147/TACG.S58444. PMC 4012343. PMID 24817816.
- ↑ Mogensen TH (April 2013). "STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties". JAKSTAT. 2 (2): e23435. doi:10.4161/jkst.23435. PMC 3710320. PMID 24058807.